Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Global superbug fight 'needs $5b a year'
antibiotics
Rising antibiotic resistance is triggering the emergence of superbugs that can cause life-threatening infections, such as MRSA or drug-resistant tuberculosis.
Scientists call for a co-ordinated response to drug resistant infections
 
A global fund of $5billion a year is needed to tackle drug-resistant infections, according to predictions by a team of international scientists.

Rising antibiotic resistance is triggering the emergence of superbugs that can cause life-threatening infections, such as MRSA or drug-resistant tuberculosis.

Writing in the journal Science, researchers called for a World Bank Trust Fund to co-ordinate the response to this growing public health crisis.

The annual sum of $5b will be required to develop global systems to monitor resistance and establish a framework to address the threat, they added. It could also speed up the development of new vaccines, diagnostics and treatments, in addition to regulatory processes to ensure medicines are used appropriately.

The group also recommended introducing targets to cut the number of resistant infections over the next five years and putting global limits on antibiotic use. In particular, they believe the use of antibiotics to promote the growth of farmed animals should be phased out across the globe.

In addition, improved access to clean water, sanitation and public health infrastructure, will reduce the spread of disease and the overall need for antibiotics, scientists argued.

Professor Mark Woolhouse from the University of Edinburgh, who took part in the research, added: "Drug resistance knows no borders, as we have seen with the spread of superbugs around the world.

"It is crucial that nations come together with appropriate financing and governance to tackle this challenge together."

Become a member or log in to add this story to your CPD history

Building Great Workplaces webinars return

News Story 1
 BVA has announced a new series of its Building Great Workplaces lunchtime webinars.

Launching from 16 July, the sessions will explore patient safety, motivation, client communication and more.

Its first webinar, exploring neurodiversity in the workplace, will take place at 1pm on Thursday, 16 July. It will feature guest speakers from The Vet Project, a group which supports neurodiversity in veterinary environments.

The following three webinars take place in September, October and November.

Booking is open on the BVA website 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.